home / stock / huma / huma articles

HUMA Articles, Humacyte Inc. - From 03/22/24

Stock Information
Company Name: Humacyte Inc.
Stock Symbol: HUMA
Market: NASDAQ
Menu
HUMA HUMA Quote HUMA Short HUMA News HUMA Articles HUMA Message Board
Get HUMA Alerts

News, Short Squeeze, Breakout and More Instantly...
Investor Optimism Improves Slightly; Dow Jumps Over 250 Points | Benzinga

The CNN Money Fear and Greed index showed a slight increase in the overall market sentiment on Thursday. U.S. stocks closed higher on Thursday...
Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024 | Benzinga

DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing univer...

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Zscaler posted better-tha...

Why Humacyte (HUMA) Shares Are Falling | Benzinga

Humacyte Inc (NASDAQ:HUMA) shares are trading lower by 29.2% to $3.08 during Friday’s session after the company announced pricing of a $40.2...
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference | Benzinga

DURHAM, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing univer...

Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than-expected thir...

Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session | Benzinga

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday. Shares of Hewlett Packard Enterprise...
Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock | Benzinga

DURHAM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing univers...

Why Is Clinical-Stage Biotechnology Platform Company Humacyte Stock Gaining Friday? | Benzinga

Humacyte, Inc. (NASDAQ:HUMA) shares are trading higher on Friday. The company announced that the U.S. FDA has accepted and granted Priori...

Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks traded mostly lower, with the Nasdaq Composite falling over 200 points on Wednesday. Shares of The Boeing Company (NYSE: BA) rose duri...
Previous 10 Next 10